Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxiconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.98 |
| ▸ | PGR | P06401 | 3/20 | 0.98 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.98 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.98 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.98 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.98 |
| ▸ | IDO1 | P14902 | 3/20 | 0.98 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.98 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.98 |
| ▸ | TACR2 | P21452 | 3/20 | 0.98 |
| ▸ | DRD1 | P21728 | 3/20 | 0.98 |
| ▸ | ACHE | P22303 | 3/20 | 0.98 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.98 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.98 |
| ▸ | HTR2A | P28223 | 3/20 | 0.98 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxiconazole SCHEMBL34519 | 0.99 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL4540297 | 0.99 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL34518 | 0.99 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL30416587 | 0.99 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL21180321 | 0.98 | CYP3A4 (0.98) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL18916734 | 0.93 | CYP3A4 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| SCHEMBL18309812 | 0.93 | IDO1 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL18916735 | 0.93 | CYP3A4 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL153417 | 0.92 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL153416 | 0.92 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200030477-A1 | SYSTEMS, DEVICES, AND METHODS INCLUDING IMPLANTABLE DEVICES WITH ANTI-MICROBIAL PROPERTIES | GEARBOX LLC (US) | 2020-01-30 | — | — | US | disclosed |
| US-10426857-B2 | Systems, devices, and methods including implantable devices with anti-microbial properties | GEARBOX, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20170007733-A1 | SYSTEMS, DEVICES, AND METHODS INCLUDING IMPLANTABLE DEVICES WITH ANTI-MICROBIAL PROPERTIES | GEARBOX LLC (US) | 2017-01-12 | — | — | US | disclosed |
| US-9474831-B2 | Systems, devices, and methods including implantable devices with anti-microbial properties | GEARBOX, LLC (US) | 2016-10-25 | — | — | US | disclosed |
| US-20120209090-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE SATE OF DELAWARE | 2012-08-16 | — | — | US | disclosed |
| US-20120041286-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2012-02-16 | — | — | US | disclosed |
| US-20120041285-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2012-02-16 | — | — | US | disclosed |
| US-20120041287-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2012-02-16 | — | — | US | disclosed |
| US-20120010481-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2012-01-12 | — | — | US | disclosed |
| US-20110275912-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2011-11-10 | — | — | US | disclosed |
| US-20110208021-A1 | Systems, devices, and methods including implantable devices with anti-microbial properties | SEARETE LLC | 2011-08-25 | — | — | US | disclosed |
| EP-1585478-B1 | USE OF SYNERGISTIC BACTERIOPHAGE LYTIC ENZYMES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS | UNIV ROCKEFELLER (US) | 2010-03-17 | — | — | EP | disclosed |
| EP-1585478-A4 | USE OF SYNERGISTIC BACTERIOPHAGE LYTIC ENZYMES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS | UNIV ROCKEFELLER (US) | 2007-09-26 | — | — | EP | disclosed |
| US-20060159671-A1 | Uses of sysnergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections | ROCKEFELER UNIVERSITY | 2006-07-20 | — | — | US | disclosed |
| US-20060073154-A1 | Group a streptococci bind to mucin and human pharyngeal cells through a sialic acid-containing receptor | THE ROCKFELLER UNIVERSITY | 2006-04-06 | — | — | US | disclosed |
| EP-1585478-A2 | USE OF SYNERGISTIC BACTERIOPHAGE LYTIC ENZYMES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS | THE ROCKEFELLER UNIVERSITY (US) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004058182-A2 | USE OF SYNERGISTIC BACTERIOPHAGE LYTIC ENZYMES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS | THE ROCKEFELLER UNIVERSITY (US) | 2004-07-15 | — | — | WO | disclosed |
| US-6608187-B2 | Homogeneously purified C1 bacteriophage lysin protein or holin protein and a nucleic acids molecule encoding them | THE ROCKEFELLER UNIVERSITY | 2003-08-19 | — | — | US | disclosed |
| US-20020058027-A1 | C1 bacteriophage lytic system | THE ROCKEFELLER UNIVERSITY | 2002-05-16 | — | — | US | disclosed |
| WO-2001090331-A2 | C1 BACTERIOPHAGE LYTIC SYSTEM | THE ROCKEFELLER UNIVERSITY (US) | 2001-11-29 | — | — | WO | disclosed |